Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q33859790)
Watch
English
Bevacizumab in Advanced Cervical Cancer: Issues and Challenges for Low- and Middle-Income Countries.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
5493276
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 March 2020
title
Bevacizumab in Advanced Cervical Cancer: Issues and Challenges for Low- and Middle-Income Countries
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
5493276
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 March 2020
main subject
bevacizumab
1 reference
based on heuristic
inferred from title
cervix uterine cancer
1 reference
based on heuristic
inferred from title
author
Bishal Gyawali
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
5493276
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 March 2020
author name string
Mahesh Iddawela
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
5493276
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 March 2020
publication date
27 July 2016
1 reference
stated in
Europe PubMed Central
PMC publication ID
5493276
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 March 2020
published in
Journal of global oncology
1 reference
stated in
Europe PubMed Central
PMC publication ID
5493276
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 March 2020
volume
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
5493276
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 March 2020
issue
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
5493276
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 March 2020
page(s)
93-97
1 reference
stated in
Europe PubMed Central
PMC publication ID
5493276
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 March 2020
cites work
Compensatory angiogenesis and tumor refractoriness
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276
retrieved
28 July 2018
A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276
retrieved
28 July 2018
First- and second-line bevacizumab in addition to chemotherapy for metastatic colorectal cancer: a United States-based cost-effectiveness analysis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276
retrieved
28 July 2018
Bevacizumab in recurrent, persistent, or advanced stage carcinoma of the cervix: is it cost-effective?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276
retrieved
28 July 2018
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276
retrieved
28 July 2018
Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276
retrieved
28 July 2018
Improved survival with bevacizumab in advanced cervical cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276
retrieved
28 July 2018
OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276
retrieved
28 July 2018
Preventing cancer with vaccines: progress in the global control of cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276
retrieved
28 July 2018
Worldwide burden of cervical cancer in 2008.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276
retrieved
28 July 2018
Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276
retrieved
28 July 2018
Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276
retrieved
28 July 2018
HPV screening for cervical cancer in rural India
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276
retrieved
28 July 2018
Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276
retrieved
28 July 2018
Changing paradigms in the systemic treatment of advanced cervical cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276
retrieved
29 October 2018
Cost-effectiveness analysis of bevacizumab combined with chemotherapy for the treatment of metastatic colorectal cancer in Japan
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276
retrieved
29 October 2018
Cost-effectiveness of cervical-cancer screening in five developing countries
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276
retrieved
29 October 2018
Bevacizumab in advanced cancer, too much or too little?
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/28717748
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/28717748
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Improved drug access in low and middle-income countries
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/28717748
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Me, Too
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/28717748
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Novel Humanitarian Aid Program: The Glivec International Patient Assistance Program-Lessons Learned From Providing Access to Breakthrough Targeted Oncology Treatment in Low- and Middle-Income Countries
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/28717748
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1200/JGO.2016.004895
1 reference
stated in
Europe PubMed Central
PMC publication ID
5493276
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 March 2020
Fatcat ID
release_bdff7v3gifgzvlfl67l67glpxq
1 reference
stated in
Fatcat
reference URL
https://api.fatcat.wiki/v0/release/bdff7v3gifgzvlfl67l67glpxq
retrieved
24 November 2022
based on heuristic
mapped directly with Wikidata item
PMC publication ID
5493276
1 reference
stated in
Europe PubMed Central
PMC publication ID
5493276
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 March 2020
PubMed publication ID
28717748
1 reference
stated in
Europe PubMed Central
PMC publication ID
5493276
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 March 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit